Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|September 10, 2013
Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective studyStephane Paul, Emilie Del Tedesco, Hubert Marotte, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2021
Extramucosal Formation and Prognostic Value of Secretory Antibodies in Rheumatoid ArthritisKlara Martinsson, Lovisa Lyttbacka Kling, Karin Roos-Ljungberg, et al.
Anticancer Research|December 11, 2012
Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapyMarc Gigante, Guorong Li, Celine Ferlay, et al.
Journal of Crohn'S & Colitis|June 4, 2018
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept StudyStephane Paul, Nicolas Williet, Thomas Di Bernado, et al.
Inflammatory Bowel Diseases|August 25, 2017
The Association Between Drug Levels and Endoscopic Recurrence in Postoperative Patients with Crohn's Disease Treated with Tumor Necrosis Factor InhibitorsShmuel Fay, Bella Ungar, Stephane Paul, et al.
Scientific Reports|June 12, 2024
Circulating immunoglobulins and transient lymphocytopenia in a sub-study of CAPRISA 012B, testing HIV monoclonal antibodies in a phase 1 trialParveen Sobia, Sharana Mahomed, Aida Sivro, et al.
Journal of Crohn'S & Colitis|October 27, 2022
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel DiseaseMathilde Barrau, Manon Duprat, Pauline Veyrard, et al.
AIDS (London, England)|November 13, 2015
Plasmacytoid dendritic cells and myeloid cells differently contribute to B-cell-activating factor belonging to the tumor necrosis factor superfamily overexpression during primary HIV infectionGwenoline Borhis, Chantal Burelout, Nada Chaoul, et al.
Cancer Gene Therapy|April 19, 2002
Tumor gene therapy by MVA-mediated expression of T-cell-stimulating antibodiesStephane Paul, Etienne Regulier, Ronald Rooke, et al.
Therapeutic Drug Monitoring|March 1, 2019
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational StudyAnne-Emmanuelle Berger, Gerard Duru, Annick de Vries, et al.
Pageof 7